و بروز عارضه تبزای غیرهمولیتیک در بیماران تاالسمی دارای تزریق خون مکرر HLA-DR ارتباط پلیمورفیسم درآللهای. (Persian)
In: Scientific Journal of Iranian Blood Transfusion Organization, Jg. 20 (2023-12-01), Heft 4, S. 267-275
academicJournal
Zugriff:
Background and Objectives β-thalassemia patients need regular blood. Regular blood transfusion has side effects. The most common of which is FNHTR. One of the causes of FNHTR is the antibody production against HLA-II antigens. HLA polymorphism vary in different communities and may affect the susceptibility or resistance to FNHTR. In this study, the relationship between HLA-DR polymorphisms and development of FNHTR in multi-transfused thalassemia patients in Tehran province was investigated. Materials and Methods In this cross-sectional study, 88 β-thalassemia major and intermediate patients with average age 38.63 11.28 with 35 being male (39.8%) and 53 female (60.2%) were enrolled and for better results, 70 thalassemia patients with FNHTR were compared with 18 thalassemia patients without FNHTR. HLA-DR genotype was investigated by PCR-SSP method. Data were analyzed by chi-squared and pearson test. Results The results of PCR-SSP showed that HLA-DRB1*11 allele had the highest prevalence (26.7%) in the total study population. No statistically significant correlation between HLA-DR alleles and development of FNHTR was observed. Although HLA-DRB1*10 as a possible genetic marker may play a role in protecting against FNHTR (p = 0.049). Conclusions In this study, no significant association between HLA-DR allele frequency and FNHTR was found. Although alleles HLA-DRB1*03, HLA-DRB1*10, HLA-DRB1*13 and HLADRB1*16 have higher prevalence in the no FNHTR group, but only in the case of HLADRB1*10 this relationship was significant and was considered as possible genetic markers against development of FNHTR. Further studies investigating HLA-II allelic levels in larger populations may provide more deep data on this association. [ABSTRACT FROM AUTHOR]
Copyright of Scientific Journal of Iranian Blood Transfusion Organization is the property of Iranian Blood Transfusion Organization Research Center and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
و بروز عارضه تبزای غیرهمولیتیک در بیماران تاالسمی دارای تزریق خون مکرر HLA-DR ارتباط پلیمورفیسم درآللهای. (Persian)
|
---|---|
Autor/in / Beteiligte Person: | تثبیتی, زینب ; مریم سادات داداش ; چگینی, آزیتا ; زادسر, مریم |
Zeitschrift: | Scientific Journal of Iranian Blood Transfusion Organization, Jg. 20 (2023-12-01), Heft 4, S. 267-275 |
Veröffentlichung: | 2023 |
Medientyp: | academicJournal |
ISSN: | 1027-9520 (print) |
Schlagwort: |
|
Sonstiges: |
|